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The indole nucleus is probably the most widely distributed het-
erocyclic ring system found in nature (Kuethe et al., 2005). Due
to the existence of a vast array of structurally diverse and biolog-
ically active indoles, it is not surprising that the indole nucleus is
an important feature in many medicinal agents and the most12 523343003; fax: +212
oo.fr (A.El. Kihel).
y. Production and hosting by
Saud University.
lsevierimportant of all structural classes in drug discovery (Smith
et al., 1998). The synthesis and reactivity of indole derivatives
have been a topic of research interest for well over a century.
Compounds which contain the pyrazole functionality con-
tinue to attract great interest due to their varied and signiﬁcant
pharmacological effects. For example, the identiﬁcation of new
and selective cox-2 inhibitors (Penning et al., 1997), for the re-
lief of pain and the treatment of the symptom of arthritis and
related diseases has been an important advance in modern
anti-inﬂammatory therapy. In a related area, heterocycle-
appended pyrazoles have been reported (Dumas et al., 2000)
to be potent and selective in inhibitors of the mitogen-
activated protein kinase p38 and consequently provide a novel
approach for the treatment of rheumatoid arthritis and related
inﬂammatory diseases.
2. Results and discussion
Due to the potent biological activity exhibited by various in-
doles derivatives, there is a continuous demand for novel
174 A.E. Kihel et al.synthetic procedures in this area. In 1990s, it has attracted
much attention, as it employs simple and readily available
starting materials. In previous papers (El Kihel et al., 2007;
El Ouar et al., 1995), we have reported some reactions of 7-
aminoindoles, in this work; we have improved the synthesis
of substituted ethyl 7-nitroindole-2-carboxylate 3(a–c) that
the synthesis of ethyl 7-nitroindole-2-carboxylate has been re-
ported (Murakami et al., 1993, 1998). The starting compounds
7-nitroindole-2-carbohydrazides 4(a–c) were prepared by the
reaction of hydrazine hydrate with substituted ethyl 7-nitroin-
dole-2-carboxylate. These hydrazides when reacted with
acetylacetone yielded (3,5-dimethyl-1H-pyrazol-1-yl)(7-nitro-
1H-indol-2-yl)ketone 5(a–c).
2.1. Preparation of substituted 2-nitrophenylhydrazones 2(a–c)
Phenylhydrazones 2(a–c) were generally prepared starting
from substituted ortho-nitroanilines 1(a–c) via diazotization,
followed by Japp Klingemann reaction using ethyl a-methy-
lacetoacetate in the presence of KOH/EtOH. Phenylhydraz-
ones 2(a–c) thus prepared consisted of Z- and E-geometrical
isomers (Scheme 1). We showed that these geometrical isomers
are rapidly interconvertible by the polyphosphoric acid as cat-R
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Scheme 1alyst used for Fischer indolization and thus give the same re-
sult on Fischer indolization.
2.2. Fischer indolization
The Fischer indolization of the phenylhydrazones 2(a–c) was
carried out mainly with polyphosphoric acid (PPA) which
caused the reaction to proceed the most rapidly instead of
other catalysts (Scheme 1).
The identiﬁcation of the indolic products 3(a–c) was based
on spectroscopic data. In the 1HNMR spectra of these prod-
ucts, we noted the upﬁeld-shifted proton NH to 10 ppm and
the disappearance of the singlet of methyl group during
Fischer indolization.
2.3. Synthesis of carbohydrazides 4(a–c)
For the synthesis of the carbohydrazide 4(a–c), we have used
the method reported by literature (Harrison et al., 2006;
Narayana et al., 2005; Farghaly, 2004). The reaction between
the ethyl 7-nitroindole-2-carboxylates and hydrazine hydrate
lead to the titled products (Scheme 1). The identiﬁcation of
the structure was based on spectroscopic data.
The 1HNMR spectra of the carbohydrazide 4a displayed
two singlets at 4.61 and 11.25 due to protons of NHNH2 group
instead of ethyl group protons in the ethyl 7-nitroindole-2-
carboxylate.
2.4. Synthesis of pyrazolylindole derivatives 5(a–c)
Acid-catalyzed substitution reactions on indole derivatives
containing only 7-nitro substituent in the benzene ring, in gen-
eral, are prohibited by the acid lability of the indole nucleus,
and in those cases where these reactions are possible, the sub-
stituent orientation and the remaining functionality are not al-
ways the most desired. Ready access has provided the impetus
to investigate synthetic schemes that might be expected to pro-
vide various indole-substituted by pyrazole moiety (Farghaly,
2004; Hiremath et al., 1988; Farhanullah et al., 2004; Jukic
et al., 1999; Przheval’skii et al., 2004). This work describes
general procedure by which (3,5-dimethyl-1H-pyrazol-1-yl)
(7-nitro-1H-indol-2-yl)ketone derivatives 5(a–c) may be conve-
niently prepared in neutral medium by the reaction of the
carbohydrazides with acetylacetone.
The establishment of the structure of these compounds 5(a–
c) has been conﬁrmed by spectroscopic data. The 1HNMR
spectra of the compound 5a showed the presence of the sharp
singlets at 2.36 and 2.62 due to protons of two methyl groups
of pyrazole moiety and the methine proton appeared at
6.04 ppm. The 13CNMR spectra of 5a exhibited two signals
at 13.2 and 13.6 assignable to carbons of two methyl groups.
The molecular ion peak at m/z 284 was observed in the mass
spectrum of 5a. These spectra data and elemental analysis sup-
ported the structure of 5a.
3. Conclusion
In this work, we report the condensation of 7-nitroindole-2-
carbohydrate derivatives with acetylacetone leading to new
(3,5-dimethylpyrazol-1-yl)(7-nitro-1H-indol-2-yl)ketones. The
structures of obtained products were established with spectro-
scopic data of proton and carbon 13 NMR, mass.
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All compounds were characterized by their 1H-NMR and 13C-
NMR spectra as well as by microanalysis or HRMS spectra.
NMR spectra were recorded on Bruker ARX 200 (200 MHz for
1H and 50.3 MHz for 13C) spectrometer (d-ppm/TMS, J-Hz);
for 13CNMR, the multiplicities were determined through DEPT.
Microanalysis were performed by the ‘‘Laboratoire Central de
Microanalyse duUATRS’’ (Rabat). Mass spectra were recorded
on a Varian MAT 311 specrtometer. Melting points were mea-
sured using a Ko¨ﬂer appartus and were uncorrected.
4.1. Preparation of o-nitrophenylhydrazones 2(a–c)
Solid NaNO2 (32 mmol) was added portion wise to a solution
of substituted ortho-nitroaniline (29 mmol) and concentrated
HCl (6.4 g) in H2O (22 ml) at 0–4 C. The resulting diazonium
salt solution was added dropwise to a solution of ethyl a-
methylacetoacetate (29 mmol) and 50% aqueous KOH in
EtOH (28 ml) at 0–7 C, and the whole was stirred for 1 h under
ice-cooling. The reaction mixture was poured into H2O and ex-
tracted with Et2O. The organic solution was dried over MgSO4
and evaporated. The residue was recrystallized from ethanol.
4.1.1. Ethyl pyruvate 2-(2-nitrophenyl)hydrazone 2a
Yield = 78%; mp= 116–118 C (Ethanol). 1HNMR (DMSO-
d6): 1.36(t, J = 7.9 Hz, 3H, CH3); 2.21(s, 3H, CH3); 4.38(q,
J = 7.9 Hz, 2H, CH2); 6.84(dd, J = 2.0 Hz, J = 8.1 Hz, 1H,
H6); 7.43(t, J = 8.1 Hz, 1H, H4); 7.55(t, J = 8.1 Hz, 1H, H5);
8.19(dd, J = 2.0 Hz, J = 8.1 Hz, 1H, H3); 10.70(br s, 1H,
NH). 13CNMR (DMSO-d6): 12.0(CH3); 14.7(CH3); 62.1
(CH2); 117,2(CH-5); 120.7(CH-4); 133.1(CH-3); 136.7(CH-6);
126.2, 139.7 (ArC); 141.0(C‚N); 165.0(CO2). HRMS, m/z:
251(M), calcd. for C11H13N3 O4: 251.090, found: 251.091.
4.1.2. Ethyl pyruvate 2-(4-methyl-2-nitrophenyl)hydrazone 2b
Yield = 71%; mp = 144–146 C (Ethanol). 1HNMR
(DMSO-d6): 1.39(t, J = 7.3 Hz, 3H, CH3); 2.24(s, 3H, CH3);
2.34(s, 3H, CH3); 4.38(q, J = 7.3 Hz, 2H, CH2); 7.40(d,
J = 9.1 Hz, 1H, H6); 7.89(dd, J = 9.1 Hz, J = 1.8 Hz, 1H,
H5); 8.01(d, J = 1.8 Hz, 1H, H3); 10.90(br s, 1H, NH).
13CNMR (DMSO-d6): 11.9(CH3); 14.7(CH3); 20.7(CH3);
62.0(CH2); 117,1(CH-6); 125.6(CH-3); 132.8(CH-5); 130.7,
132.9, 138.0(ArC); 139.0(C‚N); 165.0(CO2). HRMS, m/z:
265(M), calcd. for C12H15N3O4: 265.106, found: 265.106.
4.1.3. Ethyl pyruvate 2-(4-methoxy-2-nitrophenyl)hydrazone 2c
Yield = 73%; mp = 126–128 C (Ethanol). 1HNMR
(DMSO-d6): 1.32(t, J = 7.1 Hz, 3H, CH3); 2.19(s, 3H, CH3);
3.38(s, 3H, OCH3); 4.30(q, J = 7.1 Hz, 2H, CH2); 7.51(dd,
J = 8.3, J = 2.9 Hz, 1H, H5); 7.63(d, J = 2.9 Hz, 1H, H3);
7.85(d, J = 8.3 Hz, 1H, H6); 10.55(s, 1H, NH). 13CNMR
(DMSO-d6): 11.3(CH3); 14.3(CH3); 55.8(OCH3); 61.3(CH2);
107.1(CH-3); 118.1(CH-6); 126.4(CH-5); 132.6, 135.0(ArC);
138.7(C‚N); 153.3(C–O); 164.6(CO2). HRMS, m/z: 281(M),
calcd. for C12H15N3O5: 281.101, found: 281.101.
4.2. Synthesis of ethyl 7-nitroindole-2-carboxylate derivatives
3(a–c)
A mixture of the hydrazone 2(a–c) (7.5 mmol) and polyphos-
phoric acid (10 g) was heated at 120 C for 30 min. The reac-tion mixture was poured into water and extracted with
dichloromethane. The solvent was evaporated. The crude
product was ﬁltered and recrystallized from ethanol.
4.2.1. Ethyl 7-nitroindole-2-carboxylate 3a
Yield = 61%; mp = 94–96 C (Ethanol). 1HNMR (DMSO-
d6): 1.45(t, J = 8.4 Hz, 3H, CH3); 4.47(q, J = 8.4 Hz, 2H,
CH2); 7.23 (s, 3H, CH
3); 7.70(t, J = 9.3 Hz, 1H, H5);
8.09(dd, J = 9.3 Hz, J = 2.1 Hz, 1H, H4); 8.31(dd, J =
9.3 Hz, J = 2.1 Hz, 1H, H6); 10.29(s, 1H, NH). 13CNMR
(DMSO-d6): 14.8(CH3); 62.0(CH2); 110.1(CH-3); 120.5(CH-
6); 122.5(CH-5); 130.6(CH-4); 130.9, 131,1, 131.8, 133.9
(ArC); 161.2(CO2). HRMS, m/z: 234(M), calcd. for
C11H10N2 O4: 234.064, found: 234.064.
4.2.2. Ethyl 5-methyl-7-nitroindole-2-carboxylate 3b
Yield = 70%; mp= 108–110 C (Ethanol). 1HNMR (DMSO-
d6): 1.45(t, J = 7.1 Hz, 3H, CH3); 2.50(s, 3H, CH3); 4.47(q,
J = 7.1 Hz, 2H, CH2); 7.31(s, 1H, H
3); 7.64(d, J = 1.3 Hz,
1H, H4); 8.03(d, J = 1.3 Hz, 1H, H6); 10.25(s, 1H, NH).
13CNMR (DMSO-d6): 14.8(CH3); 21.4(CH3); 61.9(CH2);
109.1(CH-3); 123.7(CH-6): 130.5(CH-4); 128.6, 129.6, 131.0,
131.5, 133.3(ArC); 161.2(CO2). HRMS, m/z: 248(M), calcd.
for C12H12N2O4 248.080, found: 248.080.
4.2.3. Ethyl 5-methoxy-7-nitroindole-2-carboxylate 3c
Yield = 55%; mp = 144–146 C (Ethanol). 1HNMR
(DMSO-d6): 1.44(t, J = 7.1 Hz, 3h, CH3); 3.92(s, 3H,
OCH3); 4.61(q, J = 7.1 Hz, 2H, CH2); 7.23(d, J = 2.3 Hz,
1H, H4); 7.50(d, J = 2.3 Hz, 1H, H3); 7.90(d, J = 2.3 Hz,
1H, H6); 10,11(s, 1H, NH). 13CNMR (DMSO-d6):
14.3(CH3); 56.3(OCH3); 61.5(CH2); 108.5(CH-6); 110.8(CH-
3); 113.7(CH-4); 125.3, 130.2, 131.2, 133.1, 153.5(ArC);
160.7(CO2). HRMS, m/z: 264(M), calcd. for C12H12N2O5:
264.075, found: 264.075.
4.3. Synthesis of 7-nitroindole-2-carbohydrazide derivatives
4(a–c)
A mixture of (2 mmol) ethyl 7-nitroindole-2-carboxylate deriv-
atives 3(a–c), 10 mmol hydrazine hydrate and 30 ml of ethanol
was shaken at room temperature for 30 min. It was left for
about 1 h, and then the hydrazide was separated out by ﬁltra-
tion and crystallized from ethanol.
4.3.1. 7-Nitroindole-2-carbohydrazide 4a
Yield = 48%; mp > 300 C. 1HNMR (DMSO-d6): 4.61(s,
2H, NH2); 7.29(t, J = 7.1 Hz, 1H, H
5); 7.33(d, J = 1.7 Hz,
1H, H3); 8.14(dd, J = 7 Hz, J = 1 Hz, 1H, H4); 8.19(dd,
J = 7 Hz, J = 1 Hz, 1H, H6); 10,23(s, 1H, NH); 11.25(s, 1H,
NH). 13CNMR (DMSO-d6): 106.6(CH-6); 120.0(CH-3);
121.7(CH-5); 130.4(CH-4); 129.1, 131.4, 133.4, 134.0(ArC);
159.7(CO). HRMS, m/z: 220(M), calcd. for C9H8N4O3:
220.059, found: 220.060.
4.3.2. 5-Methyl-7-nitroindole-2-carbohydrazide 4b
Yield = 56%; mp > 300 C. 1HNMR (DMSO-d6): 2.48(s,
3H, CH3); 4.64(s, 2H, NH2); 7.27(d, J = 1.7 Hz, 1H, H
3);
7.98(d, J = 1 Hz, 1H, H4); 8.05(d, J = 1 Hz, 1H, H6);
10,24(s, 1H, NH); 11.18(s, 1H, NH). 13CNMR (DMSO-d6):
20.6(CH3); 105.5(CH-6); 121.8(CH-3); 130.5(CH-4); 127.5,
176 A.E. Kihel et al.129.6, 131.3, 132.7, 133.8(ArC); 159.4(CO). HRMS, m/z:
234(M), calcd. for C10H10N4O3: 234.075, found: 234.075.
4.3.3. 5-Methoxy-7-nitroindole-2-carbohydrazide 4c
Yield = 56%; mp > 300 C. 1HNMR (DMSO-d6): 3.85(s,
3H, 0CH3); 4.59(s, 2H, NH2); 7.22(d, J = 1.8 Hz, 1H, H
3);
7.72(d, J = 2.4 Hz, 1H, H4); 7.74(s, J = 2.4 Hz, 1H, H6);
10.19(s, 1H, NH); 11.06(s, 1H, NH). 13CNMR (DMSO-d6):
56.2(OCH3); 105.7(CH-6); 109.2(CH-4); 113.9(CH-3); 124.6,
131.9, 132.8, 135.0, 153.3(ArC); 159.7(CO). HRMS, m/z:
250(M), calcd. for C10H10N4O4: 250.070, found: 250.071.
4.4. Condensation of 7-nitroindole-2-carbohydrazide derivatives
4(a–c) with acetylacetone
The 7-nitroindole-2-carbohydrazide derivatives 4(a–c) (2.4
mmol) and acetylacetone (3.6 mmol) were heated under reﬂux
for 5 h. After cooling, the obtained solid product was ﬁltered
off, and then recrystallized from ethanol.
4.4.1. (3,5-Dimethylpyrazol-1-yl)(7-nitro-1H-indol-2-yl)ketone
5a
Yield = 48%; mp > 300 C. 1HNMR (DMSO-d6): 2.36(s,
3H, CH3); 2.62(s, 3H, CH3); 6.04(s, CHpyrazolic); 7.37(t,
J = 8.5 Hz, 1H, H5); 7.58(d, J = 1.9 Hz, 1H, H3); 8.27(dd,
J = 8.5 Hz, J = 2.1 Hz, 1H, H4); 8.38(dd, J = 8.5 Hz,
J = 2.1 Hz, 1H, H6); 12,42(s, 1H, NH). 13CNMR (DMSO-
d6): 13.2(CH3); 13.6(CH3); 110.2(CHpyrazolic); 114.0(CH-6);
114.9(CH-3); 123.2(CH-5); 126.8(CH-4); 132.2, 136.0, 138.5,
138.9, 143.2, 152.3(ArC); 162.8(CO). HRMS, m/z: 284(M),
calcd. for C14H12N4O3: 284.091, found: 284.090. Analysis:
C14H12N4O3 (284.3); calcd. C 59.15, H 4.25, N 19.71; found
C 59.17, H 4.41, N 18.81.
4.4.2. (3,5-Dimethylpyrazol-1-yl)(5-methyl-7-nitro-1H-indol-2-
yl)ketone 5b
Yield = 56%; mp > 300 C. 1HNMR (DMSO-d6): 2.39(s,
3H, CH3); 2.50(s, 3H, CH3); 2.65(s, 3H, CH3); 6.07(s, 1H,
CHpyrazolic); 7.26(d, J = 2.3 Hz, 1H, H3); 7.63(d,
J = 1.7 Hz, 1H, H4); 8.11(d, J = 1.9 Hz, 1H, H6); 12.28(s,
NH). 13CNMR (DMSO-d6): 13.6(CH3); 14.8(CH3);
20.9(CH3); 111.1(CHpyrazolic); 113.7(CH-3); 124.0(CH-6);
130.6(CH-4); 128.6, 129.5, 131.4, 132.1, 133.3, 146.2,
153.1(ArC); 157.8(CO). HRMS, m/z: 298(M), calcd for
C15H14N4O3: 298.107, found: 298.106. Analysis: C15H14N4O3
(298.3); calcd. C 60.40, H 4.73, N 18.78; found C 60.60, H
4.94, N 18.04.
4.4.3. (3,5-Dimethylpyrazol-1-yl)(5-methoxy-7-nitro-1H-indol-
2-yl)ketone 5c
Yield = 56%; mp > 300 C. 1HNMR (DMSO-d6): 2.41(s, 3H,
CH3); 2.67(s, 3H, CH3); 3.91(s, 3H, OCH3); 6.08(s, 1H, CHpy-
razolic); 7.54(d, J = 2.7 Hz, 1H, H3); 7.69(d, J = 1.9 Hz, 1H,H4); 7.95(d, J = 3.3 Hz, 1H, H6); 12,27(s, 1H, NH). 13CNMR
(DMSO-d6): 13.4(CH3); 14.8(CH3); 56.2(OCH3); 111.1(CHpy-
razolic); 112.0(CH-3); 113.3(CH-6); 113.4(CH-4); 109.7, 114.1,
125.8, 130.4, 132.9, 146.1, 153.4(ArC); 153.5(CO). HRMS,m/z:
314(M), calcd. for C15H14N4O4: 314.102, found: 314.103. Anal-
ysis: C15H14N4O4 (314.3); calcd. C 57.32, H 4.49, N 17.83;
found C 57.41, H 4.69, N 17.09.
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